Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema.
Am J Ophthalmol. 2022 Jun;238:157-172. doi: 10.1016/j.ajo.2022.01.004. Epub 2022 Jan 14.
Am J Ophthalmol. 2022.
PMID: 35038415
Free article.
Clinical Trial.
Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes.
Zarranz-Ventura J, Parrado-Carrillo A, Nguyen V, Sararols L, Garay-Aramburu G, Puzo M, Arruabarrena C, Figueras-Roca M, Gillies MC, Casaroli-Marano RP; from the writing committee of the Fight Retinal Blindness Spain (FRB! Spain) Users Group.
Zarranz-Ventura J, et al.
Clin Exp Ophthalmol. 2022 Apr;50(3):312-324. doi: 10.1111/ceo.14054. Epub 2022 Feb 20.
Clin Exp Ophthalmol. 2022.
PMID: 35106882
Free article.
Item in Clipboard
Cite
Cite